DNLI – Marketing Sentinel

Tag: DNLI

Home

Science

Following Its 52-Week Low, Denali Therapeutics Inc. (NASDAQ: DNLI)’S Share Price Rose 41.67% And Its YTD Numbers Fell -22.20%

During the last session, Denali Therapeutics Inc. (NASDAQ:DNLI)’s traded shares were 0.57 million, with the beta value of the company hitting 1.67. At the end

Technologies

Denali Therapeutics Inc. (NASDAQ:DNLI) Gained 1.00% In A Week: What’s Driving The Stock?

In last trading session, Denali Therapeutics Inc. (NASDAQ:DNLI) saw 0.49 million shares changing hands with its beta currently measuring 1.65. Company’s recent per share price

[class^="wpforms-"]